We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+39.3%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$7.46B
AUM Growth
+$995M
(+15%)
Cap. Flow
-$777M
Cap. Flow
% of AUM
-10.41%
Top 10 Holdings %
Top 10 Hldgs %
43.11%
Holding
851
New
66
Increased
156
Reduced
545
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oneok
OKE
|
+$19.7M |
| 2 |
Newell Brands
NWL
|
+$17.6M |
| 3 |
Newmont
NEM
|
+$6.91M |
| 4 |
Coty
COTY
|
+$5.93M |
| 5 |
Vir Biotechnology
VIR
|
+$5.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$139M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
+$127M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$83.7M |
| 4 |
Enterprise Products Partners
EPD
|
+$76.4M |
| 5 |
Energy Transfer Partners
ET
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 52.96% |
| 2 | Financials | 9.94% |
| 3 | Healthcare | 5.17% |
| 4 | Technology | 4.58% |
| 5 | Consumer Discretionary | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Aprea Therapeutics
APRE
$7.83M
| $1.11M | 0.01% |
1,436
-472
| -25% | -$310K |
|
302
Mastercard
MA
$477B
| $1.11M | 0.01% |
3,760
-6,021
| -62% | -$1.7M |
|
303
Chemed
CHE
$6.78B
| $1.11M | 0.01% |
2,450
+1,830
| +295% | +$817K |
|
304
TransUnion
TRU
$14.8B
| $1.1M | 0.01% |
12,687
+337
| +3% | +$26.9K |
|
|
IMGN
305
DELISTED
Immunogen Inc
IMGN
| $1.09M | 0.01% |
237,910
-75,503
| -24% | -$321K |
|
306
Gen Digital
GEN
$15.6B
| $1.08M | 0.01% |
54,610
+3,152
| +6% | +$64.2K |
|
|
AIV
307
Aimco
AIV
$380M
| $1.08M | 0.01% |
215,580
-40,882
| -16% | -$203K |
|
308
Douglas Emmett
DEI
$2.06B
| $1.07M | 0.01% |
35,040
-1,419
| -4% | -$42.5K |
|
309
Corpay
CPAY
$24.2B
| $1.05M | 0.01% |
4,189
+143
| +4% | +$33.9K |
|
310
Assembly Biosciences
ASMB
$506M
| $1.04M | 0.01% |
3,720
-980
| -21% | -$229K |
|
|
PDM
311
Piedmont Realty Trust
PDM
$1.22B
| $1.03M | 0.01% |
62,214
-2,336
| -4% | -$39K |
|
312
Commault Systems
CVLT
$5.89B
| $1.01M | 0.01% |
26,153
+4,304
| +20% | +$171K |
|
313
AeroVironment
AVAV
$7.57B
| $1M | 0.01% |
12,559
-1,448
| -10% | -$93.2K |
|
|
OYST
314
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $990K | 0.01% |
34,264
-4,568
| -12% | -$138K |
|
315
Korro Bio
KRRO
$153M
| $984K | 0.01% |
846
-273
| -24% | -$247K |
|
316
Krystal Biotech
KRYS
$9.88B
| $982K | 0.01% |
23,719
-7,751
| -25% | -$373K |
|
|
AKRO
317
DELISTED
Akero Therapeutics
AKRO
| $975K | 0.01% |
39,113
-12,805
| -25% | -$293K |
|
|
SPLK
318
DELISTED
Splunk Inc
SPLK
| $970K | 0.01% |
4,881
-1,352
| -22% | -$214K |
|
319
Regeneron Pharmaceuticals
REGN
$68.8B
| $967K | 0.01% |
1,551
+1,096
| +241% | +$622K |
|
|
VMW
320
DELISTED
VMware, Inc
VMW
| $964K | 0.01% |
6,223
-462
| -7% | -$63.5K |
|
321
Azenta
AZTA
$1.26B
| $959K | 0.01% |
21,681
-1,638
| -7% | -$62.7K |
|
322
StoneCo
STNE
$2.62B
| $951K | 0.01% |
24,527
+2,798
| +13% | +$81.6K |
|
323
Okta
OKTA
$24.1B
| $949K | 0.01% |
4,741
-1,427
| -23% | -$242K |
|
|
ABB
324
DELISTED
ABB Ltd
ABB
| $938K | 0.01% |
41,597
+2,695
| +7% | +$51.8K |
|
325
Apple Hospitality REIT
APLE
$3.96B
| $933K | 0.01% |
96,600
-45,514
| -32% | -$433K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ALPS Advisors held 851 positions worth $7.46B, up 15% from $6.46B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
ALPS Advisors withdrew a net $777M in Q2 2020, closing 77 positions and reducing 545 holdings. Its most notable exit was EQM Midstream Partners, LP, an estimated $127M position sold in full.
By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 51% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ALPS Advisors opened a new position in Newell Brands worth $20.3M.
- ALPS Advisors's largest Q2 2020 buy was Newell Brands: 1,279,812 shares worth $20.3M.
- ALPS Advisors added most to Oneok in Q2 2020, an estimated $19.7M increase.
- ALPS Advisors's biggest Q2 2020 reduction was MPLX, cutting an estimated $139M.
- ALPS Advisors fully exited EQM Midstream Partners, LP in Q2 2020, selling an estimated $127M.
- ALPS Advisors's ten largest holdings make up 43% of its $7.46B portfolio in Q2 2020.
- ALPS Advisors opened 66 new positions and closed 77 in Q2 2020.
- ALPS Advisors's portfolio value rose 15% quarter-over-quarter to $7.46B.
Based on ALPS Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.